Latest Headlines

Latest Headlines

Using CRISPR, Temple team eliminates HIV from T-cells

HIV particles infecting a human T cell--Courtesy of NIH/NIAID Finding a cure for HIV has been a priority since its emergence in the 1980s, but the virus' ability to hide itself within...

Two HIV-preventing vaginal ring studies promise protection for women in developing countries

Vaginal rings that release antiretroviral drugs to prevent AIDS hold promise in developing countries to stem the spread of the disease and empower women by allowing them to control their own drug regimens. And research communities are hailing two new trials in Africa for safety and efficacy.

Survey: Rates of HIV in Asia could reflect 'hidden epidemic'

China now counts more than half a million people with HIV/AIDS, and a new survey suggests that caseload reflects what could be a "hidden epidemic" in the Asia-Pacific region. Much of the recent increase is among adolescents.

Generic alcoholism drug used to flush dormant HIV

Actually eradicating the virus that causes AIDS has been thwarted by the virus' ability to hide out in dormant cells. Now researchers say that a generic alcoholism drug called disulfiram has demonstrated the ability to wake up the virus and flush it out for destruction.

India's Cipla gets first FDA approval of oral pellet to treat HIV/AIDS in infants

India's Cipla recently got FDA approval for a pediatric formulation of the combo drug lopinavir/ritonavir to treat HIV/AIDS in the developing world, but not in the U.S., where market exclusivity rules apply.

UPDATED: NIH funds studies of J&J;'s and GSK's injectable HIV meds, says daily pills lead to noncompliance

In bid to improve patient adherence, the U.S. National Institutes of Health is funding and helping run two clinical trials of long-acting injectable HIV candidates being developed by Johnson & Johnson's Janssen and GlaxoSmithKline.

Drug-loaded milk could offer oral HIV/AIDS prevention to children

HIV/AIDS prevention can be difficult in countries with limited resources, especially when it comes to the millions of affected children who are less likely to tolerate antiretroviral drugs. In an effort to overcome this challenge, researchers at Penn State University have developed a delivery system for the antiretroviral Ritonavir that uses a protein in cow's milk for oral administration of the drug.

Indian drugmakers scramble to prevent shortages of HIV/AIDS meds

Some Indian companies that had put off production of HIV/AIDS meds while they waited for the government to sign contracts are now having to seriously ramp up because of shortages of some meds, Reuters reports.

HIV spikes reveal clues for vaccine development

New technology has allowed researchers to view HIV proteins in action, zooming in on so-called spikes that help the virus bind to cells it infects. The research puts scientists one step closer to a vaccine that could effectively prevent transmission of HIV and halt the spread of AIDS, an international epidemic.

Monkey study reveals clues for HIV eradication

A new sheds light on three different factors that may have contributed to ridding HIV from the "Berlin patient."